PRESS RELEASE published on 06/07/2024 at 17:45, 2 years 1 month ago Changes in the rights attaching to the classes of shares or securities Median Technologies discloses total voting rights and share capital as of May 31, 2024, in compliance with French regulations. The company specializes in AI-driven solutions for cancer diagnosis and treatment Share Capital Voting Rights AI Solutions Median Technologies Cancer Diagnosis
BRIEF published on 05/29/2024 at 17:50, 2 years 2 months ago Median Technologies to Attend 2024 ASCO Annual Meeting in Chicago Clinical Trials Oncology Imaging Solutions Median Technologies ASCO Annual Meeting
PRESS RELEASE published on 05/29/2024 at 17:45, 2 years 2 months ago Inside Information / Other news releases Median Technologies to participate in the 2024 ASCO Annual Meeting at McCormick Place, Chicago, IL, USA. Abstract on double reading performance in lung clinical trials. Event details and company overview Clinical Trials Oncology Medical Imaging Median Technologies ASCO Annual Meeting
BRIEF published on 05/21/2024 at 17:50, 2 years 2 months ago Median Technologies strengthens its position with pharmaceutical giants Artificial Intelligence Oncology Medical Imaging Median Technologies Clinical Tests
BRIEF published on 05/10/2024 at 17:50, 2 years 2 months ago Median Technologies Announces Update on Shares Voting Rights Voting Rights Median Technologies Share Structure French Corporate Law Non-voting Shares
PRESS RELEASE published on 05/10/2024 at 17:45, 2 years 2 months ago Changes in the rights attaching to the classes of shares or securities Press release about disclosing the total number of voting rights and shares in Median Technologies as of April 30th, 2024 Voting Rights Shares Median Technologies Innovative Imaging Solutions French SME Equity
Published on 08/06/2026 at 08:05, 31 minutes ago Tocvan Drills Significant Discovery On Mezquite Trend Gran Pilar 215M Of 0.6 G/T AU, From 36.6M Downhole
Published on 08/06/2026 at 03:35, 5 hours 1 minute ago Tunkillia Upgrade Drilling – 39,000m Phase 2 Complete Targeting JORC Resource Classification Upgrades; PFS Underway
Published on 08/06/2026 at 01:40, 6 hours 56 minutes ago Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor
Published on 08/05/2026 at 23:40, 8 hours 56 minutes ago Galantas Gold Secures Key Permitting Approvals for Andacollo Gold Project
Published on 08/05/2026 at 23:10, 9 hours 26 minutes ago Ur-Energy Announces Date for Second Quarter 2026 Results and Conference Call and Webcast
Published on 08/06/2026 at 08:05, 31 minutes ago Norlase Expands European Footprint with Direct Commercial Operations in Germany
Published on 08/06/2026 at 08:00, 36 minutes ago Partners Group enters into exclusive talks to acquire Aroma-Zone, one of the fastest-growing natural beauty and wellness brands in Europe
Published on 08/06/2026 at 08:00, 36 minutes ago 11880 Solutions AG: EBITDA up by 82 per cent in the first half of 2026
Published on 08/06/2026 at 08:00, 36 minutes ago Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program
Published on 08/06/2026 at 08:00, 36 minutes ago EURAZEO ENTERS INTO EXCLUSIVE DISCUSSIONS WITH PARTNERS GROUP REGARDING THE CONTEMPLATED SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT
Published on 08/05/2026 at 18:00, 14 hours 36 minutes ago Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 14 hours 46 minutes ago Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 14 hours 51 minutes ago Information concerning the total number of voting rights and shares 2026 07 31
Published on 08/05/2026 at 17:45, 14 hours 51 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
